Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Andros Pharmaceuticals Co., Ltd. (6917) Financial Statements

Andros Pharmaceuticals Co., Ltd. Financial Overview

Andros Pharmaceuticals Co., Ltd.'s market cap is currently NT$1.71B. The company's EPS TTM is NT$-0.63; its P/E ratio is -48.57; Andros Pharmaceuticals Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 5.55MNT$ 203.00KNT$ 805.00KNT$ 1.71MNT$ 13.31M
Gross ProfitNT$ -4.96MNT$ 10.00KNT$ 313.00KNT$ 966.00KNT$ 8.59M
Operating IncomeNT$ -75.64MNT$ -89.61MNT$ -73.71MNT$ -40.71MNT$ -36.61M
EBITDANT$ -68.87MNT$ -71.65MNT$ -61.50MNT$ -34.35MNT$ -29.74M
Net IncomeNT$ -53.78MNT$ -78.28MNT$ -68.16MNT$ -41.18MNT$ -37.13M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 370.24MNT$ 353.02MNT$ 442.61MNT$ 254.69MNT$ 67.68M
Total AssetsNT$ 558.97MNT$ 441.48MNT$ 529.15MNT$ 329.60MNT$ 120.27M
Total DebtNT$ 16.86MNT$ 22.03MNT$ 27.12MNT$ 31.25MNT$ 34.56M
Net DebtNT$ -36.90MNT$ -16.82MNT$ -241.89MNT$ -56.94MNT$ 19.93M
Total LiabilitiesNT$ 43.25MNT$ 47.31MNT$ 58.04MNT$ 50.12MNT$ 51.60M
Stockholders' EquityNT$ 515.72MNT$ 394.17MNT$ 471.11MNT$ 279.48MNT$ 68.66M
Cash Flow
Free Cash FlowNT$ -46.44MNT$ -83.42MNT$ -47.22MNT$ -35.80MNT$ -35.87M
Operating Cash FlowNT$ -45.45MNT$ -78.90MNT$ -46.64MNT$ -35.76MNT$ -35.87M
Investing Cash FlowNT$ -107.95MNT$ -147.51MNT$ -27.33MNT$ -137.79MNT$ 25.90M
Financing Cash FlowNT$ 169.83MNT$ -5.10MNT$ 255.01MNT$ 247.12MNT$ 9.23M

Currency in TWD

Andros Pharmaceuticals Co., Ltd. Earnings and Revenue History

-100M-50M050M-45000 %-30000 %-15000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Andros Pharmaceuticals Co., Ltd. Liabilities to Assets

0200M400M600M0 %15 %30 %45 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Andros Pharmaceuticals Co., Ltd. Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Andros Pharmaceuticals Co., Ltd. Forecast EPS vs Actual EPS

Earnings >